Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
A New Role for the p85-Phosphatidylinositol 3-Kinase
Regulatory Subunit Linking FRAP to p70 S6 Kinase Activation*
Ana
González-García,
Elia
Garrido,
Carmen
Hernández,
Beatriz
Alvarez,
Concepción
Jiménez,
Doreen A.
Cantrell§,
Nicholas
Pullen¶, and
Ana
C.
Carrera
From the Department of Immunology and Oncology,
Centro Nacional de Biotecnología, Consejo Superior de
Investigaciones Científicas, Carretera de Colmenar Km 15, Cantoblanco, Madrid E-28049, Spain, the § Imperial Cancer
Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, United
Kingdom, and the ¶ Friedrich Miescher Institute, Maulbeerstrasse
66, CH-4058, Basel, Switzerland
The serine/threonine kinase p70 S6 kinase
(p70S6K) phosphorylates the 40 S ribosomal protein S6, modulating the
translationof an mRNA subset that encodes ribosomal proteins and
translationelongation factors. p70S6K is activated in response to
mitogenicstimuli and is required for progression through the
G1 phase ofthe cell cycle and for cell growth.
Activation of p70S6K is regulatedby phosphorylation of seven different
residues distributed throughoutthe protein, a subset of which depends
on the activity of p85/p110phosphatidylinositol 3-kinase (PI3K);
in fact, the phosphorylationstatus of Thr229 and
Thr389 is intimately linked to PI3K activity. In the
full-length enzyme,however, these sites are also acutely sensitive to
the actionof FKBP 12-rapamycin-associated protein (FRAP). The
mechanismby which PI3K and FRAP cooperate to induce p70S6K activation
remainsunclear. Here we show that the p85 regulatory subunit of PI3Kalso controls p70S6K activation by mediating formation of a ternarycomplex with p70S6K and FRAP. The p85 C-terminal SH2 domain isresponsible for p85 coupling to p70S6K and FRAP, because deletionof
the C-terminal SH2 domain inhibits complex formation and impairsp70S6K activation by PI3K. Formation of this complex is not requiredfor activation of a FRAP-independent form of p70S6K, however,underscoring the role of p85 in regulating FRAP-dependent
p70S6Kactivation. These studies thus show that, in addition to the
contributionof PI3K activity, the p85 regulatory subunit plays a
criticalrole in p70S6Kactivation.
The editors suggest the following Related Resources on Science sites:
VIRTUAL JOURNAL
Hyun Kang, Helga Schneider, and Christopher E. Rudd (4 January 2002) J. Biol. Chem.277 (2), 912.
[DOI: 10.1074/jbc.M107648200] |Abstract »|Full Text »|PDF »
Klaus Okkenhaug and Bart Vanhaesebroeck (16 January 2001) Sci. STKE2001 (65), pe1.
[DOI: 10.1126/scisignal.652001pe1] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cancer-derived mutations in the regulatory subunit p85{alpha} of phosphoinositide 3-kinase function through the catalytic subunit p110{alpha}.
M. Sun, P. Hillmann, B. T. Hofmann, J. R. Hart, and P. K. Vogt (2010)
PNAS
107, 15547-15552
|Abstract »|Full Text »|PDF »
The Phosphatase Subunit Tap42 Functions Independently of Target of Rapamycin to Regulate Cell Division and Survival in Drosophila.
K. D. Cygnar, X. Gao, D. Pan, and T. P. Neufeld (2005)
Genetics
170, 733-740
|Abstract »|Full Text »|PDF »
Luteolin Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis; Inhibition of Endothelial Cell Survival and Proliferation by Targeting Phosphatidylinositol 3'-Kinase Activity.
E. Bagli, M. Stefaniotou, L. Morbidelli, M. Ziche, K. Psillas, C. Murphy, and T. Fotsis (2004)
Cancer Res.
64, 7936-7946
|Abstract »|Full Text »|PDF »
TOR signaling in mammals.
A. C. Carrera (2004)
J. Cell Sci.
117, 4615-4616
|Full Text »|PDF »
From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors.
J. Zhu, J.-W. Huang, P.-H. Tseng, Y.-T. Yang, J. Fowble, C.-W. Shiau, Y.-J. Shaw, S. K. Kulp, and C.-S. Chen (2004)
Cancer Res.
64, 4309-4318
|Abstract »|Full Text »|PDF »
3-Phosphoinositide-Dependent Protein Kinase-1/Akt Signaling Represents a Major Cyclooxygenase-2-Independent Target for Celecoxib in Prostate Cancer Cells.
S. K. Kulp, Y.-T. Yang, C.-C. Hung, K.-F. Chen, J.-P. Lai, P.-H. Tseng, J. W. Fowble, P. J. Ward, and C.-S. Chen (2004)
Cancer Res.
64, 1444-1451
|Abstract »|Full Text »|PDF »
Rapamycin-resistant Proliferation of CD8+ T Cells Correlates with p27kip1 Down-regulation and bcl-xL Induction, and Is Prevented by an Inhibitor of Phosphoinositide 3-Kinase Activity.
J. M. Slavik, D.-G. Lim, S. J. Burakoff, and D. A. Hafler (2004)
J. Biol. Chem.
279, 910-919
|Abstract »|Full Text »|PDF »
Phosphatidic Acid Regulates Systemic Inflammatory Responses by Modulating the Akt-Mammalian Target of Rapamycin-p70 S6 Kinase 1 Pathway.
H.-K. Lim, Y.-A. Choi, W. Park, T. Lee, S. H. Ryu, S.-Y. Kim, J.-R. Kim, J.-H. Kim, and S.-H. Baek (2003)
J. Biol. Chem.
278, 45117-45127
|Abstract »|Full Text »|PDF »
RGD-containing Peptides Activate S6K1 through {beta}3 Integrin in Adult Cardiac Muscle Cells.
S. Balasubramanian and D. Kuppuswamy (2003)
J. Biol. Chem.
278, 42214-42224
|Abstract »|Full Text »|PDF »
Temporal alterations in protein signaling cascades during recovery from muscle atrophy.
T. E. Childs, E. E. Spangenburg, D. R. Vyas, and F. W. Booth (2003)
Am J Physiol Cell Physiol
285, C391-C398
|Abstract »|Full Text »|PDF »
Mechanism of Ribosomal p70S6 Kinase Activation by Granulocyte Macrophage Colony-stimulating Factor in Neutrophils: COOPERATION OF A MEK-RELATED, THR421/SER424 KINASE AND A RAPAMYCIN-SENSITIVE, mTOR-RELATED THR389 KINASE.
J. A. Lehman, V. Calvo, and J. Gomez-Cambronero (2003)
J. Biol. Chem.
278, 28130-28138
|Abstract »|Full Text »|PDF »
Phosphoinositide 3-Kinase Activation Regulates Cell Division Time by Coordinated Control of Cell Mass and Cell Cycle Progression Rate.
B. Alvarez, E. Garrido, J. A. Garcia-Sanz, and A. C. Carrera (2003)
J. Biol. Chem.
278, 26466-26473
|Abstract »|Full Text »|PDF »